ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA
Clinical trials for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA trials appear
Sign up with your email to follow new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to calm inflammation in rare heart disease
Disease control CompletedThis early-phase study tested a drug called IC14 in one adult with arrhythmogenic cardiomyopathy (ACM), a rare heart condition that can cause dangerous heart rhythms. The goal was to see if the drug is safe and reduces inflammation, using blood tests, heart scans, and recordings …
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA
Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Heart cell DNA tested for better diagnosis of rare condition
Knowledge-focused CompletedThis study looked at whether DNA can be taken from heart muscle cells during a routine heart mapping procedure to help diagnose arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare heart condition. Researchers tested 34 adults to see if they could get good-quality DNA f…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC